I

Inhalerx Ltd
ASX:IRX

Watchlist Manager
Inhalerx Ltd
ASX:IRX
Watchlist
Price: 0.025 AUD Market Closed
Market Cap: AU$5.3m

Net Margin

-158.3%
Current
Improving
by 653.4%
vs 3-y average of -811.7%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-158.3%
=
Net Income
AU$-1.3m
/
Revenue
AU$837.6k

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-158.3%
=
Net Income
AU$-1.3m
/
Revenue
AU$837.6k

Peer Comparison

Country Company Market Cap Net
Margin
AU
Inhalerx Ltd
ASX:IRX
5.4m AUD
Loading...
US
Veeva Systems Inc
NYSE:VEEV
35.7B USD
Loading...
US
Cerner Corp
LSE:0R00
31.3B USD
Loading...
AU
Pro Medicus Ltd
ASX:PME
19.4B AUD
Loading...
JP
M3 Inc
TSE:2413
1.3T JPY
Loading...
US
Doximity Inc
NYSE:DOCS
7.3B USD
Loading...
SE
Sectra AB
STO:SECT B
43.7B SEK
Loading...
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD
Loading...
CN
Winning Health Technology Group Co Ltd
SZSE:300253
25.6B CNY
Loading...
IN
Inventurus Knowledge Solutions Ltd
NSE:IKS
272.9B INR
Loading...
US
Vocera Communications Inc
F:V00
2.4B EUR
Loading...

Market Distribution

In line with most companies in Australia
Percentile
39th
Based on 4 004 companies
39th percentile
-158.3%
Low
-16 177 900% — -544.7%
Typical Range
-544.7% — 3.1%
High
3.1% — 3 174 540%
Distribution Statistics
Australia
Min -16 177 900%
30th Percentile -544.7%
Median -27.7%
70th Percentile 3.1%
Max 3 174 540%

Inhalerx Ltd
Glance View

Market Cap
5.3m AUD
Industry
Health Care

InhaleRx Ltd. engages in the development and commercialization of medical technologies. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-01-11. The firm is focused on developing inhaled therapies and medicine delivery systems. The company offers Medihale, an inhaler device with sealed pod designed for use of medical cannabis inhaled formulations. The company utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic created when combusting plant material such as tobacco or cannabis leaves of flowers. The sealed tamper proof Medihale Pods provide patients with the additional Medical Cannabis c-liquid security. Its Medihale Starter Kit Pro comes with inhaler battery controller with universal serial bus (USB) charging cable, protective charging case and protective charging case USB charging cable.

IRX Intrinsic Value
0.007 AUD
Overvaluation 71%
Intrinsic Value
Price
I
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-158.3%
=
Net Income
AU$-1.3m
/
Revenue
AU$837.6k
What is Inhalerx Ltd's current Net Margin?

The current Net Margin for Inhalerx Ltd is -158.3%, which is above its 3-year median of -811.7%.

How has Net Margin changed over time?

Over the last 3 years, Inhalerx Ltd’s Net Margin has increased from -819% to -158.3%. During this period, it reached a low of -3 713.1% on Dec 31, 2022 and a high of -84.9% on Jun 30, 2024.

Back to Top